Abstract 204 Table 1
General characteristics
Age (years)
46±12.8
Disease duration (months)
121.3±92.4 (min-max:6–132)
Gender (Female/Male)
139 (92.7%)/11 (7.3%)
SLEDAI
min-max:0–30, median:1.5
SLICC/ACR damage index
min-max:0–5, median:0